These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 25173557)
1. Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives. Pia Schiavone BI; Verotta L; Rosato A; Marilena M; Gibbons S; Bombardelli E; Franchini C; Corbo F Anticancer Agents Med Chem; 2014; 14(10):1397-1401. PubMed ID: 25173557 [TBL] [Abstract][Full Text] [Related]
2. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent. Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112 [TBL] [Abstract][Full Text] [Related]
3. DNA-protective activities of hyperforin and aristoforin. Ševčovičová A; Šemeláková M; Plšíková J; Loderer D; Imreová P; Gálová E; Kožurková M; Miadoková E; Fedoročko P Toxicol In Vitro; 2015 Apr; 29(3):631-7. PubMed ID: 25678043 [TBL] [Abstract][Full Text] [Related]
4. Hyperforin: more than an antidepressant bioactive compound? Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991 [TBL] [Abstract][Full Text] [Related]
5. Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis. Martínez-Poveda B; Verotta L; Bombardelli E; Quesada AR; Medina MA PLoS One; 2010 Mar; 5(3):e9558. PubMed ID: 20224821 [TBL] [Abstract][Full Text] [Related]
7. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature]. Bouron A; Lorrain E Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060 [TBL] [Abstract][Full Text] [Related]
8. Hyperforin, a new lead compound against the progression of cancer and leukemia? Quiney C; Billard C; Salanoubat C; Fourneron JD; Kolb JP Leukemia; 2006 Sep; 20(9):1519-25. PubMed ID: 16791262 [TBL] [Abstract][Full Text] [Related]
9. Improved Bioactivity of the Natural Product 5-Lipoxygenase Inhibitor Hyperforin by Encapsulation into Polymeric Nanoparticles. Traeger A; Voelker S; Shkodra-Pula B; Kretzer C; Schubert S; Gottschaldt M; Schubert US; Werz O Mol Pharm; 2020 Mar; 17(3):810-816. PubMed ID: 31967843 [TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of hyperforin and its hydrogenated analogue on bacterial growth and biofilm production. Schiavone BI; Rosato A; Marilena M; Gibbons S; Bombardelli E; Verotta L; Franchini C; Corbo F J Nat Prod; 2013 Sep; 76(9):1819-23. PubMed ID: 23981190 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into the antileukemic activity of hyperforin. Billard C; Merhi F; Bauvois B Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417 [TBL] [Abstract][Full Text] [Related]
12. Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo. Rothley M; Schmid A; Thiele W; Schacht V; Plaumann D; Gartner M; Yektaoglu A; Bruyère F; Noël A; Giannis A; Sleeman JP Int J Cancer; 2009 Jul; 125(1):34-42. PubMed ID: 19326439 [TBL] [Abstract][Full Text] [Related]
13. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Martínez-Poveda B; Quesada AR; Medina MA Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844 [TBL] [Abstract][Full Text] [Related]
15. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats. Butterweck V; Winterhoff H; Herkenham M Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894 [TBL] [Abstract][Full Text] [Related]
16. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells. Šemeláková M; Mikeš J; Jendželovský R; Fedoročko P J Photochem Photobiol B; 2012 Dec; 117():115-25. PubMed ID: 23099482 [TBL] [Abstract][Full Text] [Related]
17. Hyperforin acts as an angiogenesis inhibitor. Schempp CM; Kiss J; Kirkin V; Averbeck M; Simon-Haarhaus B; Kremer B; Termeer CC; Sleeman J; Simon JC Planta Med; 2005 Nov; 71(11):999-1004. PubMed ID: 16320199 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line. Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577 [TBL] [Abstract][Full Text] [Related]
19. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect]. Vacek J; Klejdus B; Kubán V Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301 [TBL] [Abstract][Full Text] [Related]
20. In-vitro antitumor activity evaluation of hyperforin derivatives. Sun F; Liu JY; He F; Liu Z; Wang R; Wang DM; Wang YF; Yang DP J Asian Nat Prod Res; 2011 Aug; 13(8):688-99. PubMed ID: 21751836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]